Disc Medicine

IRONNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.973 B

$77.44 +0.00%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$212.2M

Loss-making

Shares outstanding

38,392,844

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#80uniQureQURE$3.22B
#81Arcutis BiotherapeuticsARQT$3.18B
#82Disc MedicineIRON$2.97B
#83ImmunomeIMNM$2.83B
#84Supernus PharmaceuticalsSUPN$2.77B

Where these numbers come from

Share counts and financials for Disc Medicine are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.